Acute myeloid leukemia trials in Greece

In Greece 8 Also abroad 761

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Enrolling by invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Where
Athens
Age
18 years and over
People
120 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00
Phase 3Taking people
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Where
Alexandroupoli, Athens, Chaïdári, Ioannina, Rio, Thessaloniki
Age
18 years and over
People
600 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06852222 · EU 2024-520154-38-00
Phase 3Taking people
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Where
Chaïdári, Larissa, Patras
Age
12 years and over
People
468 worldwide
Run by
Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00
No phaseTaking people
Early Detection and Screening of Hematological Malignancies - SANGUINE
Where
Athens
Age
18 years and over
People
3,000 worldwide
Run by
JaxBio Ltd
See details and how to joinNCT05735704
Phase 3Taking people
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Where
Alexandroupoli, Athens, Chaïdári, Ioannina, Thessaloniki
Age
18 years and over
People
1,300 worldwide
Run by
Kura Oncology, Inc.
See details and how to joinNCT07007312 · EU 2025-521314-25-00
Phase 2Taking people
Administration of Gilteritinib to eliminate MRD in patients with AML and FLT3-ITD mutation.
Where
Athens, Chaïdári, Thessaloniki
Age
18 years and over
People
58
Run by
Hellenic Society Of Hematology
See details and how to join2025-521875-30-00 · EU 2025-521875-30-00
Phase 3Taking people
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
Where
Athens
Age
18 years and over
People
245 worldwide
Run by
Servier Affaires Médicales
See details and how to joinNCT05907057 · EU 2022-501709-11-00
Phase 1/2Taking people
AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Where
athens, Athens, Patra
Age
18 years and over
People
78 worldwide
Run by
AB Science
See details and how to joinNCT05211570 · EU 2024-516641-39-00